← Eichor
Condition: Immune Deficiency Disorder Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Immune Deficiency Disorder

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Five Point Initiative: A Bundled Implementation Strategy to Address the HIV Epidemic in Black Communities
NA · 1 location(s) · University of Miami · NCT06062342
An mHealth Intervention to Improve Outcomes for Women With HIV/AIDS
NA · 1 location(s) · University of Miami · NCT03738410
A Phase I/II Clinical Study of CTS3497 in Patients With MTAP Deficient Malignacies
Phase 1/Phase 2 · 1 location(s) · CytosinLab Therapeutics Co., Ltd. · NCT06971523
Lenacapavir Intensification to Disrupt HIV Reservoirs in Virologically Suppressed People With HIV Receiving Antiretrovir
Phase 1 · 1 location(s) · National Institute of Allergy and Infectious Diseases (NIAID · NCT06819176
Development of a New Family of HIV Latency Regulators (LRAs) Targeting the Tat Viral Protein
Phase N/A · 1 location(s) · University Hospital, Montpellier · NCT06441123
One-stop PrEP Care Pathway to Simplify PrEP Delivery in Kenya: The One-Stop PrEP Care Project
NA · 1 location(s) · University of Washington · NCT05905640
Toxin Exposure and Immune Dysregulation in Non-Hodgkin Lymphoma
Phase N/A · 3 location(s) · Henry M. Jackson Foundation for the Advancement of Military · NCT07652580
A Natural History Study Seeks to Understand the Clinical, Genomic, Pharmacological, Laboratory, and Dietary Determinates
Phase N/A · 1 location(s) · National Human Genome Research Institute (NHGRI) · NCT06092346
Phase 1/2: CD45RA Depleted Stem Cell Addback to Prevent Viral or Fungal Infections Post TCRab/CD19 Depleted HSCT
Phase 1/Phase 2 · 1 location(s) · Children's Hospital of Philadelphia · NCT06839456
REINItiation of Antiretroviral Therapy Using Oral bicTegravir, emtrIcitAbine and Tenofovir alafenamidE
Phase 4 · 10 location(s) · CAN Community Health · NCT07476339
Pathogenic Study of Adult Immune Enteropathies
Phase N/A · 4 location(s) · Institut National de la Santé Et de la Recherche Médicale, F · NCT04280510
Role of Antibiotic Therapy or Immunoglobulin On iNfections in hAematoLogy: Immunoglobulin Stopping or Extension
Phase 2/Phase 3 · 7 location(s) · Monash University · NCT05678621
A Pilot Study of an Online HIV Stigma Training for Nursing Students in Iran
NA · 1 location(s) · University of California, San Francisco · NCT06509113
Augmented Renal Clearance in Neurocritical Care
Phase N/A · 3 location(s) · University of Alberta · NCT07410624
Early Life Malnutrition, Environmental Enteric Dysfunction and Microbiome Trajectories
Phase N/A · 1 location(s) · University of Zimbabwe · NCT07195006
An Effectiveness Trial of the PrEP for WINGS Study
NA · 1 location(s) · Columbia University · NCT06853314
Pathophysiology of Inborn Immunodeficiencies
Phase N/A · 1 location(s) · University of Zurich · NCT03422614
Efficacy, Acceptability and Safety of Event-driven HIV PrEP Using TAF/FTC in MSM in Thailand and France.
Phase 3 · 4 location(s) · ANRS, Emerging Infectious Diseases · NCT05813964
Let's Get REAL: Family Health Communication Tool in Pediatric Stem Cell Transplant and Cellular Therapy
NA · 1 location(s) · Washington University School of Medicine · NCT06689800
INcentives and ReMINDers to Improve Long-term Medication Adherence (INMIND)
NA · 1 location(s) · RAND · NCT06949774
Pharmacokinetics of Antiretroviral Agents in HIV-infected Pregnant Women.
Phase N/A · 21 location(s) · Radboud University Medical Center · NCT00825929
Comprehensive HIV and Harm Prevention Via Telehealth
NA · 2 location(s) · University of Miami · NCT05897099
Genetic Study of Immunodeficiency: Search for New Genetic Causes for Primary Immunodeficiencies
Phase N/A · 1 location(s) · University Children's Hospital, Zurich · NCT02735824
Clinical Trial to Evaluate the Safety and Immunogenicity of Hiltonol, Poly-ICLC-adjuvanted CD40.HIVRI.Env (VRIPRO) in Ad
Phase 1 · 9 location(s) · National Institute of Allergy and Infectious Diseases (NIAID · NCT06665646
Clozapine-related Immunodeficiency in Parkinsons Disease
Phase 4 · 1 location(s) · Centre Hospitalier Universitaire, Amiens · NCT06634641
Safety, Tolerability and Effectiveness of DTG/3TC vs BIC/TAF/FTC in PWH Without Antiretroviral Experience
Phase 4 · 1 location(s) · Instituto Mexicano del Seguro Social · NCT07031063
Feasibility of HPV Testing With Mail-delivered Sample Collection Kits
Phase N/A · 1 location(s) · University of California, San Francisco · NCT07087145
Usage of Spirometry in Managing IgG Therapy in CVID With Airway Disease
Phase 4 · 1 location(s) · University of Alabama at Birmingham · NCT05193552
Accurate Staging of Immuno-virological Dynamics During Acute HIV Infection
Phase N/A · 1 location(s) · University Hospital, Ghent · NCT03449706
An Economic and Relationship-strengthening Intervention to Reduce Alcohol Use in Malawi
NA · 1 location(s) · University of California, San Francisco · NCT06367348
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.